 Connection
Sarah Rowan to Male
This is a "connection" page, showing publications Sarah Rowan has written about Male.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.248 |
|
|
|
-
Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 02; 8(2):e114-e120.
Score: 0.027
-
Rowan SE, Kamis KF, Beum R, Bryan K, Gawenus L, Colon Sanchez D, Hurley H. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020 09 02; 222(Suppl 5):S384-S391.
Score: 0.027
-
Rowan SE, Muething L, Spielmann K, Blum J, Lou Y, Vaughn S, Burman WJ. The Yield of Birth Cohort Screening for Hepatitis C in Community Health Centers. J Gen Intern Med. 2019 10; 34(10):2003-2004.
Score: 0.025
-
Haukoos JS, Rowan SE. Screening for HIV infection. BMJ. 2016 Jan 19; 532:i1.
Score: 0.020
-
Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS. 2014 Sep; 28(9):475-82.
Score: 0.018
-
Rowan SE, Levi ME, Youngwerth JM, Brauer B, Everson GT, Johnson SC. The variable presentations and broadening geographic distribution of hepatic fascioliasis. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):598-602.
Score: 0.015
-
Toerper MF, Haukoos J, Hopkins E, Rowan SE, Lyons MS, Galbraith JW, Hsieh YH, White DA, Levin S, Hinson J, Rothman RE. Use of Epic? to facilitate high-quality randomization of emergency department-based pragmatic clinical trials. Clin Trials. 2025 Apr; 22(2):142-151.
Score: 0.009
-
Bianchini ML, Rowan SE, Frost HM, Valuck R, McQueen RB, Anderson HD. Trends in Demographic Characteristics and Risk Factors Among Individuals With Syphilis in Colorado From 2011 to 2020. Sex Transm Dis. 2025 Jun 01; 52(6):345-351.
Score: 0.009
-
Bredenberg E, Callister C, Dafoe A, Holliman BD, Rowan SE, Calcaterra SL. Subspecialty physicians' perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study. Harm Reduct J. 2024 07 25; 21(1):140.
Score: 0.009
-
Haukoos J, Hopkins E, Campbell JD, Lyons MS, Rothman RE, Hsieh YH, White DAE, Trent S, Al-Tayyib AA, Gardner EM, Sabel AL, Rowan SE. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial. Ann Emerg Med. 2024 Sep; 84(3):234-243.
Score: 0.009
-
Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana. J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241258559.
Score: 0.009
-
Obafemi OA, Rowan SE, Nishiyama M, Wendel KA. Mycoplasma genitalium: Key Information for the Primary Care Clinician. Med Clin North Am. 2024 Mar; 108(2):297-310.
Score: 0.008
-
Shepard Z, Vargas Barahona L, Montalbano G, Rowan SE, Franco-Paredes C, Madinger N. Bartonella quintana Infection in People Experiencing Homelessness in the Denver Metropolitan Area. J Infect Dis. 2022 10 07; 226(Suppl 3):S315-S321.
Score: 0.008
-
Brooks KM, Castillo-Mancilla JR, Morrow M, Mawhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah L, Tehrani A, Jimmerson LC, Roon L, Bushman LR, Anderson PL, Kiser JJ. Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use. J Antimicrob Chemother. 2022 04 27; 77(5):1396-1403.
Score: 0.008
-
Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e22.
Score: 0.007
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. Am J Emerg Med. 2022 01; 51:6-12.
Score: 0.007
-
Haukoos JS, Lyons MS, Rothman RE, White DAE, Hopkins E, Bucossi M, Ruffner AH, Ancona RM, Hsieh YH, Peterson SC, Signer D, Toerper MF, Saheed M, Pfeil SK, Todorovic T, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Gardner EM, Rowan SE, Sabel AL, Thrun MW. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2021 07 01; 4(7):e2117763.
Score: 0.007
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care STDS. 2021 06; 35(6):211-219.
Score: 0.007
-
Obafemi OA, Wendel KA, Anderson TS, Scott TE, Rowan SE, Travanty EA, Rietmeijer CA. Rapid Syphilis Testing for Men Who Have Sex With Men in Outreach Settings: Evaluation of Test Performance and Impact on Time to Treatment. Sex Transm Dis. 2019 03; 46(3):191-195.
Score: 0.006
-
Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
Score: 0.006
-
Bhatia R, Modali L, Lowther M, Glick N, Bell M, Rowan S, Keglovitz K, Schneider J. Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum. Sex Transm Dis. 2018 01; 45(1):50-55.
Score: 0.006
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|